Liu Cuili
Biographic Data
| ID | 10240429 |
|---|---|
| NAME | Liu Cuili |
| GIVEN NAMES | Liu |
| FAMILY NAME | Cuili |
| SIGNATURE | CUILI L |
| AFFILIATIONS | National Medical Products Administration |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017
Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the prevalence and trends of the utilization of IV ribavirin among reproductive age population. Objective: To evaluate the prevalence and trends of IV ribavirin use among reproductive-age population in…
No prominent works on this page.
Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017
Background: Intravenous (IV) ribavirin is not approved in US and European Union, but it is authorized in China. Significant teratogenic and embryocidal effects of ribavirin have been found in almost all animal studies, it is critical to investigate the prevalence and trends of the utilization of IV ribavirin among reproductive age population. Objective: To evaluate the prevalence and trends of IV ribavirin use among reproductive-age population in…
Adolescent and Pediatric Healthcare (1 work) · Child Nutrition and Water Access (1 work) · Cohort (1 work) · Demography (1 work) · Environmental health (1 work) · Food Security and Health in Diverse Populations (1 work) · Internal Medicine (1 work) · Marital status (1 work) · Medical prescription (1 work) · Medicine (1 work)